newsfilter
← Latest News
GlobeNewswire·

Amarin Receives National Reimbursement for VAZKEPA® in Austria

-- Austrian Health Authorities Approve VAZKEPA® (icosapent ethyl) for National Reimbursement to Reduce Risk of Cardiovascular Events in Eligible Patients -- -- Effective 1 April 2025, Austrian Reimbursement